Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.21
-0.27 (-0.95%)
At close: Apr 10, 2026, 4:00 PM EDT
28.21
0.00 (0.00%)
After-hours: Apr 10, 2026, 7:32 PM EDT
Roivant Sciences Stock Forecast
Stock Price Forecast
The 8 analysts that cover Roivant Sciences stock have a consensus rating of "Strong Buy" and an average price target of $27.56, which forecasts a -2.30% decrease in the stock price over the next year. The lowest target is $16.5 and the highest is $35.
Price Target: $27.56 (-2.30%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 4, 2026.
Analyst Ratings
The average analyst rating for Roivant Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $34 | Strong Buy | Maintains | $33 → $34 | +20.52% | Mar 4, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $26 → $35 | Strong Buy | Maintains | $26 → $35 | +24.07% | Feb 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $33 | Strong Buy | Maintains | $26 → $33 | +16.98% | Feb 10, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $28 → $30 | Strong Buy | Maintains | $28 → $30 | +6.35% | Feb 9, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $29 → $32 | Buy | Maintains | $29 → $32 | +13.43% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
11.21M
from 29.05M
Decreased by -61.42%
Revenue Next Year
109.65M
from 11.21M
Increased by 878.32%
EPS This Year
-1.30
from -0.24
EPS Next Year
-1.46
from -1.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 26.3M | 433.6M | ||||
| Avg | 11.2M | 109.7M | ||||
| Low | 7.5M | 12.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -9.6% | 3,768.2% | ||||
| Avg | -61.4% | 878.3% | ||||
| Low | -74.0% | 14.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -1.11 | -0.71 | ||||
| Avg | -1.30 | -1.46 | ||||
| Low | -1.56 | -1.86 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.